Y Intercept (Hong Kong) LTD Bausch Health Companies Inc. Call Options Transaction History
Y Intercept (Hong Kong) LTD
- $1.27 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BHC
# of Institutions
281Shares Held
278MCall Options Held
21.5MPut Options Held
21.8M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$247 Million3.29% of portfolio
-
Goldentree Asset Management LP New York, NY27.6MShares$197 Million23.66% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$188 Million20.29% of portfolio
-
Franklin Resources Inc San Mateo, CA15.9MShares$113 Million0.06% of portfolio
-
National Bank Of Canada15.7MShares$111 Million0.29% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.57B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...